| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2025―Oct―25 |
Decoding Fibrosis in Non-Resolvable COVID-19: a role for myeloid-specific HIF1A deletion |
Kemly Philip, Hannah P Thompson, Scott D Collum, Isabella Lefebvre, Bindu Akkanti, Bihong Zhao, et al. (+5) Rahat Hussain, Manish Patel, Michael R. Blackburn, Tingting W. Mills, Harry Karmouty-Quintana |
| 2 |
[GO] |
2024―Nov―08 |
Convergent and divergent immune aberrations in COVID-19, post-COVID-19-Interstitial Lung Disease and Idiopathic Pulmonary Fibrosis |
Bochra Tourki, Minxue Jia, Theodoros Karampitsakos, Iset M Vera, Alyssa Arsenault, Zainab Fatima, et al. (+14) Carole Y Perrot, Dylan Allen, Forouzandeh Farsaei, David Rutenberg, Debabrata Bandyopadhyay, Ricardo Restrepo-Jaramillo, Muhammad R Qureshi, Kapilkumar Patel, Argyris Tzouvelekis, Maria Kapetanaki, Brenda Juan-Guardela, Kami Kim, Panayiotis V Benos, Jose D Herazo-Maya |
| 3 |
[GO] |
2023―Jul―03 |
Cellular microRNAs target SARS-CoV-2 spike protein and restrict viral replication |
Kishore Vaddadi, Chaitanya Gandikota, Chaoqun Huang, Yurong Liang, Lin Liu |
| 4 |
[GO] |
2022―Dec―02 |
Proteoglycans: A common portal for SARS-CoV-2 and extracellular vesicle uptake |
Myriam Cerezo-Magaña, Anna Bång-Rudenstam, Mattias Belting |
| 5 |
[GO] |
2022―Apr―20 |
The role of Hyaluronan synthesis and degradation in the critical respiratory illness COVID-19 |
Nansy Albtoush, Aaron C. Petrey |
| 6 |
[GO] |
2022―Feb―23 |
Serially passaged, conditionally reprogrammed nasal epithelial cells as a model to study epithelial functions and SARS-CoV-2 infection |
Hanna Schmidt, Lara Gutjahr, Alexander Sauter, Fabian Zech, Rayhane Nchioua, Steffen Stenger, et al. (+4) Manfred Frick, Frank Kirchhoff, Paul Dietl, Oliver H. Wittekindt |
| 7 |
[GO] |
2022―Feb―09 |
The atlas of ACE2 expression in fetal and adult human hearts reveals the potential mechanism of heart injured patients infected with SARS-CoV-2 |
Xiuli Shao, Xiaolin Zhang, Ruijia Zhang, Rongli Zhu, Xiuyang Hou, Weijue Yi, et al. (+3) Fengmin Wu, Liying Hao, Rui Feng |
| 8 |
[GO] |
2021―Nov―24 |
Long-term Complications of COVID-19 |
Amar D. Desai, Michael Lavelle, Brian C. Boursiquot, Elaine Wan |
| 9 |
[GO] |
2021―Jan―27 |
Soluble ACE2 as a potential therapy for COVID-19 |
Sudarshan Krishnamurthy, Richard F Lockey, Narasaiah Kolliputi |
| 10 |
[GO] |
2020―Nov―05 |
Mitochondrial metabolic manipulation by SARS-CoV-2 in peripheral blood mononuclear cells of COVID-19 patients |
Saima Ajaz, Mark J McPhail, Keshav K Singh, Salma Mujib, Francesca M Trovato, Salvatore Napoli, Kosh Agarwal |
| 11 |
[GO] |
2020―Jul―20 |
Inhibiting Fusion with Cellular Membrane System: Therapeutic Options to Prevent Severe Acute Respiratory Syndrome Coronavirus-2 Infection. |
PRASENJIT MITRA |
| 12 |
[GO] |
2020―Jun―09 |
H2S as a potential defence against COVID-19? |
Guangdong Yang |
| 13 |
[GO] |
2020―Jun―08 |
Decoding SARS-CoV-2 Hijacking of Host Mitochondria in Pathogenesis of COVID-19 |
Keshav K Singh, Gyneshwar Chaubey, Jake Y Chen, Prashanth Suravajhala |
|
